EN
TradingView
Ticker Trading Ideas Educational Ideas Scripts People
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following
Sign Out Go PRO Go PRO 30-day Free Trial Go PRO Early
Markets US Stocks Health Technology Biotechnology

KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS
NASDAQ
US Flag
KZIA

KZIA
KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS
US Flag
NASDAQ
 
Prev
Open
Volume
 — 
Day's Range
Prev
Open
Volume
 — 
Day's Range
Overview
Ideas Technicals

KZIA Stock Chart

Ideas

Videos only
Top authors: KZIA
Recent
PennyStock101
PennyStock101
KAZIA Therapeutics Ltd Golden Cross
KZIA, 1D
KZIA: KAZIA Therapeutics Ltd Golden Cross
129 views ・

Company profile Kazia Therapeutics Ltd. engages in the pharmaceutical drug research and development. Its pipeline includes two clinical-stage drug development candidates such as GDC-0084, and Cantrixil. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —

Profile

Sector: Health Technology
Industry: Biotechnology
Employees: ---
Kazia Therapeutics Ltd. engages in the pharmaceutical drug research and development. Its pipeline includes two clinical-stage drug development candidates such as GDC-0084, and Cantrixil. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

News

Community & Tools
House Rules Moderators People Chat Brokers Stock Screener Forex Screener Crypto Screener Economic Calendar
For Business
Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Brokerage Integration Advertising Partner Program Refer a friend Content Streams & RSS
Support
Help Center Pine Script Status Page Blog Security Vulnerability Contacts
About
How It Works Features Pricing Wall of Love Terms of Use Disclaimer Privacy Policy Cookies Policy Careers
© 2019 TradingView
Stock Charts & Forex Charts
Made with
From the creators of MultiCharts
Select market data provided by ICE Data Services
Home Stock Screener Forex Screener Crypto Screener Economic Calendar Shows How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Help Center Refer a friend Feature Request Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out
Go PRO Go PRO 30-day Free Trial Go PRO Early